Clinical trials with a 22-channel cochlear prosthesis.
During 1984, six patients have been implanted with a 22-channel cochlear prosthesis. The device features a programmable wearable speech processor using a speech feature encoding strategy. A strict clinical protocol was followed, and no patients have been lost to follow-up. All patients are regular users of the device and have shown a restoration of hearing sensation in response to acoustic stimuli. Pure tone averages ranged from 20 to 47 dB HL and speech detection thresholds varied from 15 to 32.5 dB HL. All patients have shown a recognition of a large variety of environmental sounds, and an improvement in speech recognition ability when the device is used in conjunction with lipreading. Speech reception thresholds using spondee words without lipreading were obtained in three patients at levels of 27.5 to 55 dB HL and one patient had an open-set speech discrimination score (w-22 word list) of 42% without lipreading. In addition, two of the patients show an ability to have limited interactive conversation without the use of lipreading.
D000328:Adult; D001302:Audiometry, Speech; D002986:Clinical Trials as Topic; D003054:Cochlear Implants; D004867:Equipment Design; D006312:Hearing Loss, Bilateral / Q000175:diagnosis / Q000503:physiopathology / Q000534:rehabilitation; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000503:physiopathology / Q000534:rehabilitation; D006801:Humans; D008085:Lipreading; D008722:Methods; D008838:Microcomputers; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011603:Psychophysiology; D013067:Speech Perception / Q000502:physiology; D013069:Speech Reception Threshold Test